http://www.empr.com Latest articles from MPR MPR Home Concise prescription and over-the-counter drug information and news, including side effects, interactions, dosing, and contraindications. Over 3000 drugs written by pharmacists for medical professionals. Home custserv@haymarketmedia.com no Pentec Health is recalling unused nutritional prescriptions for renal patients compounded on or before May 2, 2013. http://www.empr.com/pentec-health-recalls-nutritional-prescriptions/article/293877/ Fri, 17 May 2013 20:52:25 GMT Pentec Health is recalling unused nutritional prescriptions for renal patients compounded on or before May 2, 2013. MPR Acute otitis media treatment chart including select antibiotics and recommended doses. http://www.empr.com/acute-otitis-media-treatments/article/125853/ Fri, 17 May 2013 17:00:00 GMT Acute otitis media treatment chart including select antibiotics and recommended doses. MPR Transition of Combivent Respimat is nearly complete as Boehringer Ingelheim plans to cease distribution of Combivent MDI in May. http://www.empr.com/combivent-respimat-transition-almost-complete/article/293778/ Fri, 17 May 2013 14:15:53 GMT Transition of Combivent Respimat is nearly complete as Boehringer Ingelheim plans to cease distribution of Combivent MDI in May. MPR Mylan announced that the FDA has approved Fenofibrate Tablets, the generic version of AbbVie's Tricor. http://www.empr.com/mylan-approved-for-generic-tricor/article/293777/ Fri, 17 May 2013 14:13:25 GMT Mylan announced that the FDA has approved Fenofibrate Tablets, the generic version of AbbVie's Tricor. MPR Monograph added. http://www.empr.com/lycelle-head-lice-removal-kit/scabies-and-lice/drug/20490/ Fri, 17 May 2013 04:00:00 GMT Monograph added. MPR Genetech announced results from CLL11, a Phase 3 study of obinutuzumab (GA101), comparing the combination of either obinutuzumab or Rituxan and chlorambucil to chlorambucil alone in chronic lymphocytic leukemia (CLL). http://www.empr.com/obinutuzumab-reduces-disease-progression-risk-in-cll-study/article/293689/ Thu, 16 May 2013 18:50:46 GMT Genetech announced results from CLL11, a Phase 3 study of obinutuzumab (GA101), comparing the combination of either obinutuzumab or Rituxan and chlorambucil to chlorambucil alone in chronic lymphocytic leukemia (CLL). MPR http://www.empr.com/considerations-in-the-management-of-rheumatoid-arthritis/article/278461/ Thu, 16 May 2013 17:46:00 GMT MPR The FDA has approved Simponi (golimumab for subcutaneous injection; Janssen Biotech) to induce and maintain clinical response in adults with ulcerative colitis. http://www.empr.com/simponi-approved-for-ulcerative-colitis/article/293602/ Thu, 16 May 2013 13:33:42 GMT The FDA has approved Simponi (golimumab for subcutaneous injection; Janssen Biotech) to induce and maintain clinical response in adults with ulcerative colitis. MPR Chart with different formulations and combination of drugs used to treat menopause. http://www.empr.com/hormone-replacement-therapies/article/123738/ Thu, 16 May 2013 12:30:00 GMT Chart with different formulations and combination of drugs used to treat menopause. MPR Single and combination dyslipidemia treatment options indicating which lipids can be targeted. http://www.empr.com/dyslipidemia-drug-indications/article/123682/ Thu, 16 May 2013 12:00:00 GMT Single and combination dyslipidemia treatment options indicating which lipids can be targeted. MPR Monograph added. http://www.empr.com/eletone/pruritus-and-dry-skin/drug/20488/ Thu, 16 May 2013 04:00:00 GMT Monograph added. MPR Mylan announced the launch of Zolmitriptan Tablets for the treatment of migraine with or without aura in adults. http://www.empr.com/mylan-launches-generic-zomig/article/293537/ Wed, 15 May 2013 19:58:31 GMT Mylan announced the launch of Zolmitriptan Tablets for the treatment of migraine with or without aura in adults. MPR The FDA has approved Bayer's Xofigo for the treatment of advanced prostate cancer with bone metastases. http://www.empr.com/new-drug-approved-for-advanced-prostate-cancer/article/293458/ Wed, 15 May 2013 15:59:59 GMT The FDA has approved Bayer's Xofigo for the treatment of advanced prostate cancer with bone metastases. MPR The cobas EGFR Mutation Test has been approved to identify patients with non-small cell lung cancer who are candidates for receiving Tarceva as first-line treatment. http://www.empr.com/personalized-medicine-approvals-for-lung-cancer-patients/article/293448/ Wed, 15 May 2013 15:37:41 GMT The cobas EGFR Mutation Test has been approved to identify patients with non-small cell lung cancer who are candidates for receiving Tarceva as first-line treatment. MPR The FDA has approved new dosing recommendations for zolpidem-containing products for the treatment of insomnia. http://www.empr.com/changes-to-insomnia-drug-labels-affect-dosing-warnings/article/293434/ Wed, 15 May 2013 14:09:48 GMT The FDA has approved new dosing recommendations for zolpidem-containing products for the treatment of insomnia. MPR Monograph added. http://www.empr.com/texacort/topical-steroids/drug/20495/ Wed, 15 May 2013 04:00:00 GMT Monograph added. MPR The FDA has approved a new oral formulation to help reduce fatal medication errors in improving outcome for patients with subarachnoid hemorrhage. http://www.empr.com/nymalize-may-reduce-fatal-errors-in-brain-hemorrhage-patients/article/293257/ Tue, 14 May 2013 16:28:26 GMT The FDA has approved a new oral formulation to help reduce fatal medication errors in improving outcome for patients with subarachnoid hemorrhage. MPR The FDA has accepted Seattle Genetics' sBLA for filing of Adcetris for retreatment and extended duration beyond 16 cycles of therapy in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma. http://www.empr.com/adcetris-under-review-for-retreatment-and-extended-duration-therapy/article/293251/ Tue, 14 May 2013 15:32:16 GMT The FDA has accepted Seattle Genetics' sBLA for filing of Adcetris for retreatment and extended duration beyond 16 cycles of therapy in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma. MPR Monograph added. http://www.empr.com/epiceram/pruritus-and-dry-skin/drug/20489/ Tue, 14 May 2013 04:00:00 GMT Monograph added. MPR The FDA has accepted the Biologics License Application for Eloctate, a first in class recombinant factor VIII Fc fusion protein for hemophilia A treatment. http://www.empr.com/biogen-idecs-hemophilia-a-and-b-candidates-under-review/article/293080/ Mon, 13 May 2013 14:57:20 GMT The FDA has accepted the Biologics License Application for Eloctate, a first in class recombinant factor VIII Fc fusion protein for hemophilia A treatment. MPR The FDA has granted Janssen R&D's NDA priority review for simeprevir in combination with pegylated interferon and ribavirin for the treatment of genotype 1 chronic hepatitis C in adults. http://www.empr.com/simeprevir-gets-priority-review-for-hepatitis-c/article/293079/ Mon, 13 May 2013 14:52:58 GMT The FDA has granted Janssen R&D's NDA priority review for simeprevir in combination with pegylated interferon and ribavirin for the treatment of genotype 1 chronic hepatitis C in adults. MPR The FDA has accepted for filing Actavis' NDA for a once-weekly progestin-only transdermal contraceptive patch to prevent pregnancy in women. http://www.empr.com/nda-for-progestin-only-patch-accepted-for-filing-by-fda/article/293073/ Mon, 13 May 2013 13:51:28 GMT The FDA has accepted for filing Actavis' NDA for a once-weekly progestin-only transdermal contraceptive patch to prevent pregnancy in women. MPR Apotex, on behalf of Hospira, is recalling an additional 21 lots of Piperacillin/Tazobactam for Injection due to possible precipitation and crystallization in IV bag or line after reconstitution. http://www.empr.com/more-lots-of-generic-zosyn-recalled/article/293072/ Mon, 13 May 2013 13:38:11 GMT Apotex, on behalf of Hospira, is recalling an additional 21 lots of Piperacillin/Tazobactam for Injection due to possible precipitation and crystallization in IV bag or line after reconstitution. MPR http://www.empr.com/ulcerative-colitis-therapy-distribution-discontinued-in-the-us/article/288479/ Mon, 13 May 2013 13:00:00 GMT MPR Monograph added. http://www.empr.com/rayos/corticosteroid-responsive-disorders/drug/20498/ Mon, 13 May 2013 04:00:00 GMT Monograph added. MPR Atriphen has been recalled due to the possibility of causing a severe allergic reaction from two undeclared allergens. http://www.empr.com/joint-supplement-contains-undeclared-allergens/article/292802/ Fri, 10 May 2013 14:53:20 GMT Atriphen has been recalled due to the possibility of causing a severe allergic reaction from two undeclared allergens. MPR Possible microbial contamination in sterile compounds from The Compounding Shop poses a risk of serious infection to patients. http://www.empr.com/the-compounding-shop-under-fda-investigation/article/292605/ Thu, 09 May 2013 13:49:23 GMT Possible microbial contamination in sterile compounds from The Compounding Shop poses a risk of serious infection to patients. MPR Teva has launched Levalbuterol Inhalation Solution, the generic version of Sunovion's Xopenex Inhalation Solution. Xopenex is a beta-2 agonist indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years and older with reversible obstructive airway disease. http://www.empr.com/teva-launches-generic-xopenex-solution/article/291587/ Wed, 01 May 2013 21:39:15 GMT Teva has launched Levalbuterol Inhalation Solution, the generic version of Sunovion's Xopenex Inhalation Solution. Xopenex is a beta-2 agonist indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children 6 years and older with reversible obstructive airway disease. MPR Metoclopramide Injection, the second drug to be offered in the BD Simplist ready-to-administer line of prefilled generic injectables, has been launched. Metoclopramide is an antiemetic that works by stimulating motility of the upper GI tract without stimulating gastric, biliary, or pancreatic secretions. http://www.empr.com/bd-simplists-metoclopramide-injection-released/article/290098/ Tue, 23 Apr 2013 15:44:29 GMT Metoclopramide Injection, the second drug to be offered in the BD Simplist ready-to-administer line of prefilled generic injectables, has been launched. Metoclopramide is an antiemetic that works by stimulating motility of the upper GI tract without stimulating gastric, biliary, or pancreatic secretions. MPR Lupin has received final FDA approval for Daysee Tablets, the generic version of Teva's Seasonique Tablets. Seasonique is an oral contraceptive indicated for use by women to prevent pregnancy. http://www.empr.com/lupin-launches-generic-seasonique-tablets/article/288586/ Fri, 12 Apr 2013 14:58:12 GMT Lupin has received final FDA approval for Daysee Tablets, the generic version of Teva's Seasonique Tablets. Seasonique is an oral contraceptive indicated for use by women to prevent pregnancy. MPR http://www.empr.com/new-product-for-ulcerative-colitis-patients/article/280542/ Mon, 08 Apr 2013 10:00:00 GMT MPR http://www.empr.com/optimizing-crc-screening-new-advances-in-bowel-preparation-and-insights-on-quality-measures/article/285395/ Mon, 01 Apr 2013 16:23:00 GMT MPR http://www.empr.com/xareltor-rivaroxaban-pharmacist-counselor/article/279675/ Mon, 01 Apr 2013 10:00:00 GMT MPR This patient information fact sheet provides information on the definition, symptoms, causes, diagnostic tests, treatments, and self-help measures for chronic obstructive pulmonary disease (COPD). http://www.empr.com/chronic-obstructive-pulmonary-disease-copd-patient-information-fact-sheet/article/268314/ Wed, 14 Nov 2012 19:26:30 GMT This patient information fact sheet provides information on the definition, symptoms, causes, diagnostic tests, treatments, and self-help measures for chronic obstructive pulmonary disease (COPD). MPR This patient information fact sheet provides information on the definition, causes, symptoms, diagnostic tests, treatments, and self-help measures for fibroids. http://www.empr.com/fibroids-patient-information-fact-sheet/article/267965/ Mon, 12 Nov 2012 19:04:50 GMT This patient information fact sheet provides information on the definition, causes, symptoms, diagnostic tests, treatments, and self-help measures for fibroids. MPR This patient information fact sheet provides information on the definition, causes, symptoms, diagnostic tests, and treatments for endometriosis. http://www.empr.com/endometriosis-patient-information-fact-sheet/article/267961/ Mon, 12 Nov 2012 18:51:28 GMT This patient information fact sheet provides information on the definition, causes, symptoms, diagnostic tests, and treatments for endometriosis. MPR A calculator for determining anion gap. http://www.empr.com/anion-gap-calculator/article/170197/ Fri, 14 May 2010 20:14:49 GMT A calculator for determining anion gap. MPR A calculator for determining absolute reticulocyte count (ARC). http://www.empr.com/absolute-reticulocyte-count-calculator/article/170189/ Fri, 14 May 2010 19:52:45 GMT A calculator for determining absolute reticulocyte count (ARC). MPR A calculator for determining absolute neutrophil count (ANC). http://www.empr.com/absolute-neutrophil-count-calculator/article/170179/ Fri, 14 May 2010 19:27:08 GMT A calculator for determining absolute neutrophil count (ANC). MPR Do you know enough about treatment by videoconference? Learn more in MPR's special report. http://www.empr.com/the-abcs-of-telepsychiatry/article/292834/ Mon, 01 Jan 0001 05:00:00 GMT Do you know enough about treatment by videoconference? Learn more in MPR's special report. MPR POLL: Do free samples of a medication influence you to preferentially prescribe that drug? Vote now! http://www.empr.com/opinion-polls/section/3342/ Mon, 01 Jan 0001 05:00:00 GMT POLL: Do free samples of a medication influence you to preferentially prescribe that drug? Vote now! MPR Industry professionals like yourself connect with MPR on our LinkedIn page. Join us today. http://www.linkedin.com/company/mpr---monthly-prescribing-reference Mon, 01 Jan 0001 05:00:00 GMT Industry professionals like yourself connect with MPR on our LinkedIn page. Join us today. MPR Sometimes a little bit of humor can brighten up your whole day. http://www.empr.com/cartoons/section/2826/ Mon, 01 Jan 0001 05:00:00 GMT Sometimes a little bit of humor can brighten up your whole day. MPR Vaccination of pregnant women should be considered on the basis of risk vs. benefit. Learn more with our complete clinical chart. http://www.empr.com/guidelines-for-vaccinating-pregnant-women/article/124013/ Mon, 01 Jan 0001 05:00:00 GMT Vaccination of pregnant women should be considered on the basis of risk vs. benefit. Learn more with our complete clinical chart. MPR This slideshow reviews drug information for KADCYLA (Ado-trastuzumab emtansine, powder; for IV infusion after reconstitution). http://www.empr.com/new-drug-product-kadcyla/slideshow/1323/ Mon, 01 Jan 0001 05:00:00 GMT This slideshow reviews drug information for KADCYLA (Ado-trastuzumab emtansine, powder; for IV infusion after reconstitution). MPR